CASGEVY Gets Bahrain Approval for Treatment, Marking It Second Country in the World

MANAMA, Bahrain, Dec. 02, 2023 (Korea Bizwire) — Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The treatment was developed by Vertex Pharmaceuticals and CRISPR Therapeutics, after [...]